G Cianci M F Morelli K Cannita R Morese E Ricevuto Z C Di Rocco G Porzio P Lanfiuti Baldi C Ficorella
10.1038/sj.bjc.6600967
Br J Cancer
2003 May 19;88(10):1507-9.
CC BY
https://pubmed.ncbi.nlm.nih.gov/12771913/
Angina Pectoris / chemically induced Angina Pectoris / prevention & control Antimetabolites, Antineoplastic / adverse effects Fluorouracil / adverse effects Nitroglycerin / therapeutic use Vasodilator Agents / therapeutic use
Angina Pectoris / chemically induced Angina Pectoris / prevention & control Antimetabolites, Antineoplastic / adverse effects Fluorouracil / adverse effects Nitroglycerin / therapeutic use Vasodilator Agents / therapeutic use Case Reports Aged Antimetabolites, Antineoplastic / administration & dosage Antimetabolites, Antineoplastic / therapeutic use Female Fluorouracil / administration & dosage Fluorouracil / therapeutic use Humans Male Middle Aged Neoplasms / drug therapy Antimetabolites, Antineoplastic Vasodilator Agents Nitroglycerin Fluorouracil
PMC2377120
12771913
Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity
2003